Woodtli, NadaNadaWoodtlivon Wolff, MichaelMichaelvon WolffBitterlich, NormanNormanBitterlichStute, PetraPetraStute2024-10-082024-10-082018-07https://boris-portal.unibe.ch/handle/20.500.12422/63790PURPOSE To assess the attitude towards ovarian tissue and oocyte cryopreservation for non-medical reasons. METHODS Cross-sectional electronic survey in 248 Swiss women aged 15-35 years, nationally representative for educational level. RESULTS Most women did not worry about an age-related fertility decline. Two-thirds of women would consider using hormone therapy (HT) for menopausal symptom relief although concerns about side effects and risks were still high. Acceptance of cryopreservation of oocytes (19%) or ovarian tissue (13%) for postponing fertility or menopause was generally low, but increased (37%) if both goals could be achieved with one surgery. Cryopreservation of ovarian tissue for postponing menopause was acceptable for 22% of women. Not having a suitable partner until age 35 increased the likelihood of considering postponing fertility by cryopreservation (p < 0.001) and had a stronger impact on that decision than the factor "pursuing a career" (p < 0.001). CONCLUSION More education on age-related fertility decline, menopause and HT (benefit-risk ratio) is needed. Furthermore, the political and socioeconomic discussion should focus on women's needs, especially on compatibility of career and family.enCryopreservation Fertility Hormone therapy Oocyte Ovarian tissue600 - Technology::610 - Medicine & healtharticle10.7892/boris.1258902970060110.1007/s00404-018-4778-5